Fund 13F filing

SUSQUEHANNA INTERNATIONAL GROUP, LLP added $28.2M of CRISPR Therapeutics AG (CRSP) stock

SEC Form 13F · Filed May 15, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP added $28.2M of CRISPR Therapeutics AG (CRSP) stock in the quarter ending Mar 31, 2026, per a 13F filed May 15, 2026.

A 13F shows holdings at quarter end, so the exact trade dates are not disclosed.

Bought

CRSP

CRISPR Therapeutics AG

Value

$28.2M

Disclosed: May 15, 2026
Quarter end: Mar 31, 2026
Source: SEC Form 13F

See the filing

More CRSP insider and Congress trades

SellCRSP · James R. Kasinger$626KSep 24, 2026
SellCRSP · Ali Behbahani$781KSep 21, 2026
SellCRSP · Naimish Patel$211KJun 1, 2026

Share this trade

From a public SEC Form 13F, linked above. Not investment advice, and not a recommendation to buy or sell.